← SynDRA
PETESICATIB
SynDRA canonical compound SYN0039728 — structure-anchored drug synonym record
| Clinical phase | Phase 2 |
| Primary target(s) | CTSS | CTSV |
| Mechanism of action | cathepsin inhibitor |
| Indication | sjogren's syndrome |
| Disease area | rheumatology |
All known targets
Mechanisms of action (all sources)
- CTSS INHIBITOR
- Cathepsin S inhibitor
- cathepsin inhibitor
- CTSS ANTAGONIST
Drug classes
Cross-references
Synonyms
- RG7625
- RO5459072
- RG-7625
- RO-5459072
- UNII-A26QO95U37
- A26QO95U37
- Petesicatib [INN]
- SCHEMBL700776
- GTPL9855
- KXAAIORSMACJSI-AEFFLSMTSA-N
- 2-Pyrrolidinecarboxamide, N-(1-cyanocyclopropyl)-4-((4-(1-methyl-1H-pyrazol-4-yl)-2-(trifluoromethyl)phenyl)sulfonyl)-1-((1-(trifluoromethyl)cyclopropyl)carbonyl)-, (2S,4R)-
- (2S,4R)-N-(1-cyanocyclopropyl)-4-[4-(1-methylpyrazol-4-yl)-2-(trifluoromethyl)phenyl]sulfonyl-1-[1-(trifluoromethyl)cyclopropanecarbonyl]pyrrolidine-2-carboxamide
- (2s,4r)-4-[4-(1-me
- petesicatibum
- RefChem:172118
- Petesicatib [USAN]
- Petesicatib (USAN)
- Petesicatib [USAN:INN]
- PETESICATIB [WHO-DD]
- orb1706826
- SCHEMBL31043450
- EX-A3136
- AKOS040742388
- AT32881
- DA-66593
- MS-30641
- HY-109069
- CS-0033436
- D11376
- T16474
Look up PETESICATIB in the interactive SynDRA portal →